Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Announcement & Circular
Stock Information
02186.HK
2.35 -0.07  (-2.89%)
Volume：27,570,500
12-06
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2016
Publisher：
11-30
2016
Discloseable Transaction Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business
Publisher：
11-17
2016
ANNOUNCEMENT
Publisher：
11-16
2016
CLARIFICATION ANNOUNCEMENT
Publisher：
11-01
2016
Approval for Clinical Trial for New Drug Triptorelin Acetate Extended-release Microspheres for Injection in China
Publisher：
10-04
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2016
Publisher：
09-29
2016
Interim Report 2016
Publisher：
09-06
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2016
Publisher：
08-29
2016
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2016
Publisher：
08-17
2016
NOTICE OF BOARD MEETING
Publisher：
First
46
47
48
49
50
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Stock Information
02186.HK
Volume：27,570,500
2.35
-0.07  (-2.89%)
Announcement & Circular
12-06
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2016
11-30
2016
Discloseable Transaction Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business
11-17
2016
ANNOUNCEMENT
11-16
2016
CLARIFICATION ANNOUNCEMENT
11-01
2016
Approval for Clinical Trial for New Drug Triptorelin Acetate Extended-release Microspheres for Injection in China
10-04
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2016
09-29
2016
Interim Report 2016
09-06
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2016
08-29
2016
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2016
08-17
2016
NOTICE OF BOARD MEETING
First
46
47
48
49
50
Last